R01 NS080619/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	1
2013	4
2014	5
2015	5
2016	7
2017	5
2018	2
2019	1
2020	1
2023	1
2024	0

1

Proteoglycans and their roles in brain cancer.

Wade A, Robinson AE, Engler JR, Petritsch C, James CD, Phillips JJ. Wade A, et al. FEBS J. 2013 May;280(10):2399-417. doi: 10.1111/febs.12109. Epub 2013 Feb 6. FEBS J. 2013. PMID: 23281850 Free PMC article. Review.

2

Asymmetric cell division of stem and progenitor cells during homeostasis and cancer.

Gómez-López S, Lerner RG, Petritsch C. Gómez-López S, et al. Cell Mol Life Sci. 2014 Feb;71(4):575-97. doi: 10.1007/s00018-013-1386-1. Epub 2013 Jun 15. Cell Mol Life Sci. 2014. PMID: 23771628 Free PMC article. Review.

3

Interactions between language, thought, and perception: Cognitive and neural perspectives.

Mahon BZ, Kemmerer D. Mahon BZ, et al. Cogn Neuropsychol. 2020 Jul-Sep;37(5-6):235-240. doi: 10.1080/02643294.2020.1829578. Cogn Neuropsychol. 2020. PMID: 33172363

4

Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.

Wainwright DA, Horbinski CM, Hashizume R, James CD. Wainwright DA, et al. Neurotherapeutics. 2017 Apr;14(2):385-392. doi: 10.1007/s13311-017-0523-1. Neurotherapeutics. 2017. PMID: 28321824 Free PMC article. Review.

5

Successes and challenges in modeling heterogeneous BRAF^V600E mutated central nervous system neoplasms.

Xing YL, Panovska D, Petritsch CK. Xing YL, et al. Front Oncol. 2023 Oct 18;13:1223199. doi: 10.3389/fonc.2023.1223199. eCollection 2023. Front Oncol. 2023. PMID: 37920169 Free PMC article. Review.

6

Regulation of Asymmetric Cell Division in Mammalian Neural Stem and Cancer Precursor Cells.

Daynac M, Petritsch CK. Daynac M, et al. Results Probl Cell Differ. 2017;61:375-399. doi: 10.1007/978-3-319-53150-2_17. Results Probl Cell Differ. 2017. PMID: 28409314 Review.

7

Combined BRAF^V600E and MEK blockade for BRAF^V600E-mutant gliomas.

Zhang J, Yao TW, Hashizume R, Hariono S, Barkovich KJ, Fan QW, Prados M, James CD, Weiss WA, Nicolaides T. Zhang J, et al. J Neurooncol. 2017 Feb;131(3):495-505. doi: 10.1007/s11060-016-2333-4. Epub 2016 Nov 15. J Neurooncol. 2017. PMID: 27848137 Free PMC article.

8

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.

Yao TW, Zhang J, Prados M, Weiss WA, James CD, Nicolaides T. Yao TW, et al. Oncotarget. 2015 Sep 8;6(26):21993-2005. doi: 10.18632/oncotarget.4014. Oncotarget. 2015. PMID: 26023796 Free PMC article.

9

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA. Dasgupta T, et al. J Neurooncol. 2016 Feb;126(3):385-93. doi: 10.1007/s11060-015-1939-2. Epub 2015 Sep 18. J Neurooncol. 2016. PMID: 26384810 Free PMC article.

10

Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas.

Yao TW, Zhang J, Prados M, Weiss WA, James CD, Nicolaides T. Yao TW, et al. Oncotarget. 2017 Jan 3;8(1):583-595. doi: 10.18632/oncotarget.11882. Oncotarget. 2017. PMID: 27611946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year